Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal vaginal cream plus metronidazole for bacterial vaginosis
IRCT20200721048159N10Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoints: Vaginal burning, Vaginal itching and 2 more. Started Jun 2026; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on IRCT20200721048159N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200721048159N10.